Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
Intrinsic Value
The intrinsic value of one Hubei Biocause Pharmaceutical Co Ltd stock under the Base Case scenario is 4.98 CNY. Compared to the current market price of 4.06 CNY, Hubei Biocause Pharmaceutical Co Ltd is Undervalued by 18%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Hubei Biocause Pharmaceutical Co Ltd
Fundamental Analysis


Balance Sheet Decomposition
Hubei Biocause Pharmaceutical Co Ltd
Cash & Short-Term Investments | 8.5B |
Insurance Receivable | 715m |
PP&E | 1.5B |
Long-Term Investments | 216.4B |
Other Assets | 58B |
Wall St
Price Targets
Price Targets Summary
Hubei Biocause Pharmaceutical Co Ltd
Dividends
Current shareholder yield for Hubei Biocause Pharmaceutical Co Ltd is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one Hubei Biocause Pharmaceutical Co Ltd stock under the Base Case scenario is 4.98 CNY.
Compared to the current market price of 4.06 CNY, Hubei Biocause Pharmaceutical Co Ltd is Undervalued by 18%.